Eric Nicolaï

426 total citations
18 papers, 190 citations indexed

About

Eric Nicolaï is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Eric Nicolaï has authored 18 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Eric Nicolaï's work include Synthesis and biological activity (6 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers) and Synthesis and Reactions of Organic Compounds (5 papers). Eric Nicolaï is often cited by papers focused on Synthesis and biological activity (6 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers) and Synthesis and Reactions of Organic Compounds (5 papers). Eric Nicolaï collaborates with scholars based in France, United States and Spain. Eric Nicolaï's co-authors include F. Caussade, Rafael Gozalbes, Dragos Horvath, Frédérique Barbosa, J. M. TEULON, Marie-France Paugam, Frédéric Revah, Alix Cloarec, Angéla Virone-Oddos and A. Cloarec and has published in prestigious journals such as Journal of Medicinal Chemistry, Cardiovascular Research and European Journal of Medicinal Chemistry.

In The Last Decade

Eric Nicolaï

17 papers receiving 180 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Nicolaï France 8 91 86 36 30 23 18 190
Takashi Imada Japan 9 98 1.1× 84 1.0× 19 0.5× 15 0.5× 12 0.5× 9 242
Shuqun Lin United States 8 76 0.8× 95 1.1× 26 0.7× 9 0.3× 31 1.3× 9 195
Deborah A. Mischke United States 9 133 1.5× 144 1.7× 25 0.7× 39 1.3× 11 0.5× 12 258
Isaac Hoffman United States 11 133 1.5× 68 0.8× 18 0.5× 14 0.5× 19 0.8× 13 227
Petra Johannesson Sweden 8 137 1.5× 194 2.3× 15 0.4× 33 1.1× 11 0.5× 11 356
Tammy C. Wang United States 10 98 1.1× 113 1.3× 14 0.4× 46 1.5× 11 0.5× 16 278
Maria Alessandra Alisi Italy 10 105 1.2× 139 1.6× 20 0.6× 12 0.4× 91 4.0× 16 299
David J. Schwalb United States 8 193 2.1× 99 1.2× 12 0.3× 28 0.9× 57 2.5× 8 381
Prakash C. Taunk United States 7 153 1.7× 33 0.4× 24 0.7× 13 0.4× 42 1.8× 12 258
Changyan Sun Sweden 10 111 1.2× 94 1.1× 13 0.4× 32 1.1× 11 0.5× 12 267

Countries citing papers authored by Eric Nicolaï

Since Specialization
Citations

This map shows the geographic impact of Eric Nicolaï's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Nicolaï with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Nicolaï more than expected).

Fields of papers citing papers by Eric Nicolaï

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Nicolaï. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Nicolaï. The network helps show where Eric Nicolaï may publish in the future.

Co-authorship network of co-authors of Eric Nicolaï

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Nicolaï. A scholar is included among the top collaborators of Eric Nicolaï based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Nicolaï. Eric Nicolaï is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Beauverger, Philippe, Marie‐Laure Ozoux, Alain Corbier, et al.. (2019). Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy. Cardiovascular Research. 116(2). 329–338. 36 indexed citations
2.
Gozalbes, Rafael, Frédérique Barbosa, Eric Nicolaï, Dragos Horvath, & Nicolas Froloff. (2008). Development and Validation of a Pharmacophore‐Based QSAR Model for the Prediction of CNS Activity. ChemMedChem. 4(2). 204–209. 11 indexed citations
3.
Bouillon, Jean‐Philippe, et al.. (2006). Synthesis of Original Trifluoromethylated 6‐Aryl‐pyridazines Fused with Thiazolidine or 1,2,4‐Triazole.. ChemInform. 37(20). 1 indexed citations
4.
Potin, Dominique, Eric Nicolaï, F. Caussade, et al.. (2005). De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold. Bioorganic & Medicinal Chemistry Letters. 15(4). 1161–1164. 12 indexed citations
5.
Gozalbes, Rafael, Eric Nicolaï, Marie-France Paugam, et al.. (2005). G-Protein-Coupled Receptor Affinity Prediction Based on the Use of a Profiling Dataset:  QSAR Design, Synthesis, and Experimental Validation. Journal of Medicinal Chemistry. 48(21). 6563–6574. 29 indexed citations
6.
Portella, Charles, et al.. (2005). Synthesis of Original Trifluoromethylated 6-Aryl-pyridazines Fused with Thiazolidine or 1,2,4-Triazole. Synthesis. 2006(1). 103–106. 4 indexed citations
7.
Gozalbes, Rafael, Eric Nicolaï, Marie-France Paugam, et al.. (2005). QSAR Strategy and Experimental Validation for the Development of a GPCR Focused Library. QSAR & Combinatorial Science. 24(4). 508–516. 6 indexed citations
8.
9.
10.
Nicolaï, Eric, et al.. (1996). New process for the synthesis of UP 269‐6, a 1,2,4‐triazolo[1,5‐c]pyrimidine derivative as a potent orally active angiotensin ii antagonist. Journal of Heterocyclic Chemistry. 33(4). 1307–1311. 1 indexed citations
11.
Nicolaï, Eric, et al.. (1995). Synthesis and angiotensin II receptor antagonist activity of C-linked pyrimidine derivatives. European Journal of Medicinal Chemistry. 30(5). 365–375. 7 indexed citations
12.
Nicolaï, Eric, et al.. (1994). Synthesis and Angiotensin II Receptor Antagonist Activity of C-Linked Pyrazole Derivatives.. Chemical and Pharmaceutical Bulletin. 42(8). 1617–1630. 10 indexed citations
13.
Nicolaï, Eric, et al.. (1994). Synthesis and SAR Studies of Novel Triazolopyrimidine Derivatives as Potent, Orally Active Angiotensin II Receptor Antagonists. Journal of Medicinal Chemistry. 37(15). 2371–2386. 23 indexed citations
14.
Nicolaï, Eric, et al.. (1994). New process for the synthesis of imidazo[4,5‐b]pyridine derivatives as potent orally active thromboxane a2 receptor antagonists. Journal of Heterocyclic Chemistry. 31(1). 73–75. 6 indexed citations
15.
Nicolaï, Eric, et al.. (1993). Synthesis and structure-activity relationships of novel benzimidazole and imidazo[4,5-b]pyridine acid derivatives as thromboxane A2 receptor antagonists. Journal of Medicinal Chemistry. 36(9). 1175–1187. 27 indexed citations
16.
Rodier, N., R. Céolin, V. Agafonov, et al.. (1993). Acide 4-{6-chloro-3-(4-chlorobenzyl)imidazo[4,5-b]pyridin-2-yl}-3,3-diméthylbutanoïque. Acta Crystallographica Section C Crystal Structure Communications. 49(11). 2034–2037. 1 indexed citations
17.
Nicolaï, Eric, et al.. (1992). Synthesis and aldose reductase inhibitory activity of N-(quinolinyl thiocarbonyl) glycine derivatives. European Journal of Medicinal Chemistry. 27(9). 977–984. 9 indexed citations
18.
Nicolaï, Eric. (1990). Portraits of children in Québec art 1800-1860. Corpus Université Laval (Université Laval).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takashi Imada Breakdown of academic impact, for papers by Shuqun Lin Breakdown of academic impact, for papers by Deborah A. Mischke Breakdown of academic impact, for papers by Isaac Hoffman Breakdown of academic impact, for papers by Petra Johannesson Breakdown of academic impact, for papers by Tammy C. Wang Breakdown of academic impact, for papers by Maria Alessandra Alisi Breakdown of academic impact, for papers by David J. Schwalb Breakdown of academic impact, for papers by Prakash C. Taunk Breakdown of academic impact, for papers by Changyan Sun
Rankless by CCL
2026